Arbutus Biopharma Corporation

NASDAQ:ABUS

Biotechnology

Healthcare
$4.07 +1.13%

+$0.05 today

Market cap
$623.90M
Beta
0.63
P/E (TTM)
5.4
EPS (TTM)
$0.83
52W Low $3.04High $5.10

Volume 2.44M

Average 1.76M

Private 5-step workspace

Build a ABUS investment thesis

Turn Arbutus Biopharma Corporation research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.

Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.